Lamivir HBV Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Lamivir HBV Tablet contains lamivudine, a nucleoside reverse transcriptase inhibitor (antiviral). Its labelling describes it for the treatment of chronic hepatitis B virus (HBV) infection and, at other strengths, HIV infection. It is described as not curing HIV but limiting the spread of the virus within the body, taken once daily at the same time each day.
Product Information
The following description reflects information associated with lamivudine and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of chronic hepatitis B virus (HBV) infection
- Described for the treatment of HIV infection, at the strengths indicated for that use
- Described as not curing HIV but preventing the spread of the virus within the body’s cells
Described Dosage & Administration
- Taken by mouth once daily, at about the same time each day, at the dose set by the doctor
- The healthcare provider’s instructions should be followed when taking the medicine
- Doses should not be missed, and treatment should not be stopped unless the doctor advises
Described Side Effects
Commonly described side effects include:
- Headache
- Nausea and vomiting
- Stomach pain
- Tiredness (fatigue)
- Diarrhoea
- Rarely, skin reactions or liver problems, which the doctor monitors
Common effects are described as not lasting long. Rare skin reactions or liver problems are described as needing monitoring, so the doctor may arrange frequent blood counts and liver function tests. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- The doctor should be told about any skin problems and any liver or kidney disease
- Regular blood counts and liver function tests are described as required during treatment
- Alcohol should be avoided, as it is described as increasing the risk of liver damage
- Pregnant women and breastfeeding mothers should consult their doctor before starting the medicine; a person who is HIV positive is advised not to share personal items or have unprotected sex
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains lamivudine and is used to treat chronic hepatitis B virus infection and HIV infection. It is described as not curing HIV but limiting the spread of the virus in the body. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as taken by mouth once daily at about the same time each day, at the dose set by the doctor. Doses should not be missed and treatment should not be stopped unless the doctor advises.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.